Durgical
EN
Open the app

Inherited haemolysis: spherocytosis, G6PD and pyruvate kinase deficiency

  • Look-alikes compared

Three inherited faults shorten red cell life: a weak skin, a missing antioxidant shield or a failing battery. Each has its own pattern, test and treatment.

Updated

What it is

The three classic non-immune inherited haemolytic anaemias each break a different part of the red cell. Hereditary spherocytosis is a defect in the membrane skeleton; G6PD deficiency removes the cell's defence against oxidant damage; pyruvate kinase deficiency cuts the glycolytic energy supply. All give a negative DAT, but they differ in inheritance, in whether haemolysis is constant or comes in attacks, in the smear and in how they are confirmed and treated.

The difference in one line

  • Hereditary spherocytosis: mostly autosomal dominant (ankyrin, spectrin, band 3, protein 4.2); spherocytes, raised MCHC, splenomegaly, gallstones and a family history.
  • G6PD deficiency: X-linked, so mostly men are affected; well between attacks; haemolysis after fava beans, infection or oxidant drugs (primaquine, tafenoquine, dapsone, rasburicase, some sulfonamides); bite and blister cells, Heinz bodies.
  • Pyruvate kinase deficiency: autosomal recessive; chronic haemolysis without spherocytes; raised 2,3-BPG shifts oxygen release to the tissues, so patients often tolerate their anaemia surprisingly well.
  • All three can cause neonatal jaundice; G6PD deficiency is a recognised cause of severe newborn jaundice and kernicterus.
  • Parvovirus B19 can cause an aplastic crisis in any of them, because the red cells live so briefly.

Skin, shield or battery

FeatureHereditary spherocytosisG6PD deficiencyPyruvate kinase deficiency
What failsMembrane skeleton (the skin)Antioxidant defence (NADPH)Energy supply (ATP)
InheritanceMostly autosomal dominantX-linkedAutosomal recessive
PatternConstant, extravascularAttacks after an oxidant trigger, intravascularConstant, extravascular
SmearSpherocytes; MCHC raisedBite and blister cells; Heinz bodies with special stainNo spherocytes; spiculated cells, more after splenectomy
Confirming testEMA binding by flow cytometry or osmotic fragilityG6PD activity, repeated months after an attackPyruvate kinase activity; PKLR genetic test
TreatmentFolic acid; splenectomy if severe; gallbladder surgery for stonesAvoid triggers; transfuse in severe attacksTransfusion; splenectomy in some; a pyruvate kinase activator in adults

In clinical practice

  • In Colombia, Plasmodium vivax malaria is treated with primaquine to clear the liver stage; G6PD deficiency should be considered and tested for where possible before it is given.
  • Dark urine, back pain and jaundice a day or two after fava beans or a new drug in a man suggest a G6PD attack.
  • Splenectomy in spherocytosis is delayed until after early childhood when possible, preceded by vaccines, because of infection risk.
  • Children with chronic haemolysis grow gallstones early; biliary colic in a child should prompt a search for haemolysis.
  • A newborn with early, severe jaundice and a family history of haemolysis or anaemia needs these three conditions in mind.

How it is confirmed

  • All three: haemolysis panel and DAT (negative) first, then the smear decides which test to order.
  • Spherocytes with negative DAT and a family history: EMA binding test (flow cytometry) or osmotic fragility.
  • Suspected G6PD deficiency: measure activity when the patient has recovered (about three months after an attack), or test the mother and relatives meanwhile.
  • Unexplained chronic DAT-negative haemolysis without spherocytes: red cell enzyme panel, including pyruvate kinase, and genetic testing; avoid testing soon after a transfusion.
  • Before primaquine or tafenoquine: G6PD testing (a quantitative test for tafenoquine).

Common traps

  • Diagnosing autoimmune haemolysis from spherocytes alone: spherocytosis has spherocytes too, but a negative DAT and a family history.
  • Measuring G6PD during an attack: the oldest, most deficient cells are already gone and the result can be falsely normal.
  • Testing a woman with one variant G6PD gene and calling her normal: random X inactivation can leave her with a mixed population and real risk.
  • Measuring red cell enzymes after a recent transfusion: donor cells mask the deficiency.

Test yourself

Think of the answer, then tap the question to see it.

Why is haemolysis constant in spherocytosis but episodic in G6PD deficiency?

The faulty membrane loses surface every pass through the spleen, every day; G6PD-deficient cells are normal until an oxidant stress (fava beans, infection, drugs) overwhelms their weak defence.

A man's G6PD activity was normal during an attack of haemolysis. Why repeat it later?

The oldest, most deficient cells were destroyed and young reticulocytes with more enzyme remain; testing about three months later shows the true level.

Why do patients with pyruvate kinase deficiency often feel better than their haemoglobin suggests?

The block in glycolysis builds up 2,3-BPG, which makes haemoglobin release oxygen more readily to the tissues.

Spherocytes and haemolysis: which test separates hereditary spherocytosis from warm autoimmune haemolysis?

The DAT: negative in hereditary spherocytosis, positive for IgG in warm AIHA; a family history and the EMA test support spherocytosis.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Hereditary spherocytosis: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Glucose-6-phosphate dehydrogenase deficiency (MedlinePlus, US National Library of Medicine, 2026); Pyruvate kinase deficiency: MedlinePlus Genetics (MedlinePlus, US National Library of Medicine, 2026); Hereditary spherocytic anemia (MedlinePlus, US National Library of Medicine, 2025).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.